Development of Pre-pregnancy Intervention to Reduce the Risk of Diabetes and Prediabetes

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 552 participants.

Also called NCT02617693

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 552 participants (enrolled count) (from the registry)
Sponsor
  • Novo Nordisk Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02617693
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Malaysia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02617693. Randomized; no masking; primary purpose prevention. Start 2015-11-23 (actual); primary completion 2017-12-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Development of Pre-pregnancy Intervention to Reduce the Risk of Diabetes and Prediabetes
Acronym
Jom Mama
Condition
Diabetes
Condition
Diabetes Mellitus, Type 2
Intervention (Behavioral)
lifestyle intervention
Intervention (Other)
standard antenatal care
Lead sponsor
Novo Nordisk A/S (class: industry)

Record details

Record id
cardio:ct-nct02617693
Content hash
2e09fb2935b4fd1783dc5f9b54648f5ceb0c30934f628eb693e264d8fa3daa39